ARIAD downgraded to Perform from Outperform at Oppenheimer Oppenheimer downgraded ARIAD citing valuation but raised its price target for shares to $23 from $20.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.